Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2006 1
2007 1
2008 1
2009 2
2010 1
2011 1
2012 4
2013 2
2014 1
2016 1
2017 1
2018 4
2019 2
2020 1
2021 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Mast cells signal their importance in health and disease.
Olivera A, Beaven MA, Metcalfe DD. Olivera A, et al. J Allergy Clin Immunol. 2018 Aug;142(2):381-393. doi: 10.1016/j.jaci.2018.01.034. Epub 2018 Feb 15. J Allergy Clin Immunol. 2018. PMID: 29454835 Review.
Current concepts of IgE regulation and impact of genetic determinants.
Potaczek DP, Kabesch M. Potaczek DP, et al. Clin Exp Allergy. 2012 Jun;42(6):852-71. doi: 10.1111/j.1365-2222.2011.03953.x. Clin Exp Allergy. 2012. PMID: 22909159 Review.
Immunoglobulin E (IgE) mediated immune responses seem to be directed against parasites and neoplasms, but are best known for their involvement in allergies. The IgE network is tightly controlled at different levels as outlined in this review. ...Linkage and candidate gene …
Immunoglobulin E (IgE) mediated immune responses seem to be directed against parasites and neoplasms, but are best known for their in …
Comprehensive analysis of coexpressed long noncoding RNAs and genes in breast cancer.
Dong Y, Zhang T, Li X, Yu F, Guo Y. Dong Y, et al. J Obstet Gynaecol Res. 2019 Feb;45(2):428-437. doi: 10.1111/jog.13840. Epub 2018 Oct 25. J Obstet Gynaecol Res. 2019. PMID: 30362198
AIM: To identify the differentially expressed long noncoding RNAs (lncRNAs) in breast cancer and analyze the potential roles. METHODS: RNA-sequencing data (ID: GSE52194) of breast cancer and normal breast samples were downloaded from Gene Expression Omnibus. ...ADOR …
AIM: To identify the differentially expressed long noncoding RNAs (lncRNAs) in breast cancer and analyze the potential roles. METHODS …
Transcriptome deconvolution reveals absence of cancer cell expression signature in immune checkpoint blockade response.
Guo YA, Kulshrestha T, Chang MM, Kassam I, Revkov E, Rizzetto S, Tan AC, Tan DSW, Tan IB, Skanderup AJ. Guo YA, et al. Cancer Res Commun. 2024 May 9. doi: 10.1158/2767-9764.CRC-23-0442. Online ahead of print. Cancer Res Commun. 2024. PMID: 38722600 Free article.
Using a robust transcriptome deconvolution approach, we inferred cancer and stroma-specific gene expression differences and identified cell-type specific features of ICB response across cancer types. ...In addition, we identified a group of potential immune-suppress …
Using a robust transcriptome deconvolution approach, we inferred cancer and stroma-specific gene expression differences and identifie …
Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women.
Lee JY, Park AK, Lee KM, Park SK, Han S, Han W, Noh DY, Yoo KY, Kim H, Chanock SJ, Rothman N, Kang D. Lee JY, et al. Carcinogenesis. 2009 Sep;30(9):1528-31. doi: 10.1093/carcin/bgp084. Epub 2009 Apr 16. Carcinogenesis. 2009. PMID: 19372141
Haplotype analyses supported these findings that OR10J3 and FCER1A were most significantly associated with risk for breast cancer (P = 2 x 10(-4) and 0.004, respectively). CONCLUSION: This study suggests that common genetic variants in the OR10J3 and FCER1A b …
Haplotype analyses supported these findings that OR10J3 and FCER1A were most significantly associated with risk for breast cancer
Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma.
Backes DM, Siddiq A, Cox DG, Calboli FC, Gaziano JM, Ma J, Stampfer M, Hunter DJ, Camargo CA, Michaud DS. Backes DM, et al. J Neurooncol. 2013 Jun;113(2):229-38. doi: 10.1007/s11060-013-1122-6. Epub 2013 Mar 25. J Neurooncol. 2013. PMID: 23525950 Free PMC article. Clinical Trial.
Statistically significant associations were found between rs2494262 and rs2427824 of the FCER1A gene, which encodes the alpha chain of the high affinity immunoglobulin E receptor, and glioma risk (nominal trend p values 0.01 and 0.03, respectively). ...However, our analyse …
Statistically significant associations were found between rs2494262 and rs2427824 of the FCER1A gene, which encodes the alpha chain o …
[Urticaria and angioedema].
Guillén Escalón J, Vargas Rosas MA, Mendoza Magaña E, Zepeda Ortega B, Sienra Monge JJ, del Río Navarro BE. Guillén Escalón J, et al. Rev Alerg Mex. 2007 Mar-Apr;54(2):54-65. Rev Alerg Mex. 2007. PMID: 17542246 Review. Spanish.
Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype.
Rojo-Tolosa S, Sánchez-Martínez JA, Pineda-Lancheros LE, Gálvez-Navas JM, González-Gutiérrez MV, Jiménez-Gálvez G, Pérez-Ramírez C, Morales-García C, Jiménez-Morales A. Rojo-Tolosa S, et al. Int J Mol Sci. 2023 Apr 10;24(8):7029. doi: 10.3390/ijms24087029. Int J Mol Sci. 2023. PMID: 37108192 Free PMC article.
Satisfactory response after 12 months of treatment was defined as (1) Reduction 50% of exacerbations or no exacerbations, (2) Improvement of lung function 10% FEV1, and (3) Reduction 50% of OCS courses or no OCS. Polymorphisms in the FCER1A (rs2251746, rs2427837), FCER1B ( …
Satisfactory response after 12 months of treatment was defined as (1) Reduction 50% of exacerbations or no exacerbations, (2) Improvement of …
Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel.
Lim GB, Kim YA, Seo JH, Lee HJ, Gong G, Park SH. Lim GB, et al. BMC Cancer. 2020 Nov 2;20(1):1052. doi: 10.1186/s12885-020-07399-8. BMC Cancer. 2020. PMID: 33138797 Free PMC article.
BACKGROUND: Triple-Negative Breast Cancer (TNBC) is an aggressive and complex subtype of breast cancer. ...The prediction models were assessed using a randomization test to validate the robustness (empirical P for the model of pCR = 0.015 and empirical P for the mod …
BACKGROUND: Triple-Negative Breast Cancer (TNBC) is an aggressive and complex subtype of breast cancer. ...The prediction mode …
27 results